Targeting TOR dependence in cancer
Metrics: PDF 3404 views | ?
Received: May 3, 2010, Accepted: May 5, 2010, Published: May 10, 2010A challenge in cancer therapy has been to identify targets whose function is essential for survival of malignant cells but not normal cells. This Perspective discusses recent evidence that novel inhibitors of the kinase TOR can provide an unprecedented balance of anti-cancer efficacy and tolerability.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.